Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tove Olafsen

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fc engineering: serum half-life modulation through FcRn bindingTove Olafsen
Seminars in Nuclear Medicine|March 31, 2010
Antibody vectors for imagingTove Olafsen, Anna M Wu
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibodies for molecular imaging of cancerAnna M Wu, Tove Olafsen
Current Radiopharmaceuticals|December 29, 2011
Protein targeting constructs in alpha therapyTove Olafsen, Jorgen Elgqvist, Anna M Wu
Nature Protocols|May 10, 2007
Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragmentTove Olafsen, Vania E Kenanova, Anna M Wu
Molecular Imaging and Biology|July 15, 2010
Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imagingBhaswati Barat, Vania E Kenanova, Tove Olafsen, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2009
Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPTSepideh Afshar, Tove Olafsen, Anna M Wu, et al.
Molecular Imaging and Biology|June 20, 2007
Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imagingKaty M Venisnik, Tove Olafsen, Sanjiv S Gambhir, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Cytotoxicity of Antiosteosarcoma Recombinant Immunotoxins Composed of TP-3 Fv Fragments and a Truncated Pseudomonas Exotoxin AMasanori Onda, Tove Olafsen, Yasuo Tsutsumi, et al.
Nuclear Medicine and Biology|August 4, 2009
Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEKGanesan Vaidyanathan, Emmanuelle Jestin, Tove Olafsen, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fc engineering: serum half-life modulation through FcRn bindingTove Olafsen
Seminars in Nuclear Medicine|March 31, 2010
Antibody vectors for imagingTove Olafsen, Anna M Wu
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibodies for molecular imaging of cancerAnna M Wu, Tove Olafsen
Current Radiopharmaceuticals|December 29, 2011
Protein targeting constructs in alpha therapyTove Olafsen, Jorgen Elgqvist, Anna M Wu
Nature Protocols|May 10, 2007
Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragmentTove Olafsen, Vania E Kenanova, Anna M Wu
Molecular Imaging and Biology|July 15, 2010
Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imagingBhaswati Barat, Vania E Kenanova, Tove Olafsen, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2009
Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPTSepideh Afshar, Tove Olafsen, Anna M Wu, et al.
Molecular Imaging and Biology|June 20, 2007
Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imagingKaty M Venisnik, Tove Olafsen, Sanjiv S Gambhir, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Cytotoxicity of Antiosteosarcoma Recombinant Immunotoxins Composed of TP-3 Fv Fragments and a Truncated Pseudomonas Exotoxin AMasanori Onda, Tove Olafsen, Yasuo Tsutsumi, et al.
Nuclear Medicine and Biology|August 4, 2009
Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEKGanesan Vaidyanathan, Emmanuelle Jestin, Tove Olafsen, et al.
Pageof 6